Abstract:Background The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis. Recent studies indicate that the inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and the tumor suppressor p53 are fundamental play-markers of the angiogenic process. Overexpression of iNOS and VEGF has been shown to induce angiogenesis in tumors. P53 suppresses angiogenesis by down-regulating VEGF and iNOS. The correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis, however, has not been well characterized. Methods The expression of p53, iNOS and VEGF in gastric precancerous and cancerous lesions and its relation with the clinical features was determined with immunohistochemistry (avidin-biotin-peroxidase complex method) on 55 randomly selected GC patients and 60 symptom-free subjects from the mass survey in the high-incidence area for GC in Henan, northern China. Results The positive immunostainig rates for p53, iNOS and VEGF in gastric carcinomas were 51%, 44% and 51%, respectively, and correlated well with TNM stages, but did not show significant difference among the groups with different degrees of gastric wall invasion depth by GC. A positive immunostaining reaction for the iNOS protein was significantly correlated with lymph node metastasis (p = 0.019; Spearman correlation coefficient). P53 protein accumulation was higher in the poorly-differentiated gastric carcinoma than in well-differentiated one. In gastric biopsies, no positive immunosatining was observed for p53, iNOS and VEGF in the histologically normal tissue and chronic superficial gastritis (CSG). However, p53, iNOS and VEGF positive immunostaining was observed in the tissues with different severities of lesions of chronic atrophic gastritis (CAG), intestinal metaplasia (IM) and dysplasia (DYS), and the positive rates increased with the lesion progression from CAG to IM to DYS. A high coincidental positive and negative immunostaining rate for p53, iNOS and VEGF was observed both in biopsy samples with CAG, IM and DYS from the symptom-free subjects and in gastric cancer tissue from the GC patients. Conclusions The present results indicated that p53 protein accumulation and increased expression of iNOS and VEGF might be responsible for gastric carcinogenesis and tumor aggressiveness of gastric cancer.

Expression and significance of p16 INK4a and Ki67 in the gastric cancer and precancerous lesions

Significance of Vascular Endothelial Growth Factor Expression and Its Correlation with Inducible Nitric Oxide Synthase in Gastric Cancer

[Expression of Tissue Microarray P53, P16 and Cyclooxygenase-2 in Gastric Cancer].

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expression of p16INK4a in human malignant tumors and its clinical significance

Expression and Clinical Signiifcance of p16 and Ki-67 in Cervical Intraepithelial Neoplasia

Expression and corelation of activated c-Src protein tyrosine kinase, HER2 and Ki-67 in gastric cancer

Expression and Signification of p53 and p16 in Cervical Intraepithelial Neoplasia and Cervical Carcinoma.

Studies on Apoptosis and the Expression of PCNA、P16 in Gastric Cancer

Research on expressions of P16 and P53 proteins and PCNA in elderly patients with gastric cancer

Relationship between precancerous gastric lesions and cell proliferation and apoptosis in a high-risk population

P16ink4a Protein is a Specific Molecular Biomarker of Breast Cancer

Clonality and Ki-67 Protein Expression in Gastric Carcinoma and Precancerous Lesions

P16ink4a Immunohistochemical Staining and Predictive Value for Progression of Cervical Intraepithelial Neoplasia Grade 1: a Prospective Study in China.

Expression Of Tumor Suppressor Gene P16, Mutant P53 And C-Erbb-2 Protein In Patients With Gastric Carcinoma

Expression of SENP1 and P53 Proteins in Gastric and Cancer Its Significance

Expression of P53, Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Gastric Precancerous and Cancerous Lesions: Correlation with Clinical Features

The comparison of the expressions of p16ink4a and Ki-67 human cervical lesions

Clinicopathological Parameters of Cervical Cancer Based on the Expression of P16ink4a Proteins

The relationship between the expression levels of p53 and Ki67 in gastric cancer tissues and the quality of life and clinical prognosis of patients with gastric cancer

The Expression and Clinical Significance of P53,P21 and P185 in Gastric Cancer